Pregnane X receptor mediates sorafenib resistance in advanced hepatocellular carcinoma

Kinase inhibitor sorafenib is the most widely used drug for advanced HCC clinical treatment nowadays. However, sorafenib administration is only effective for a small portion of HCC patients, and the majority develop sorafenib-resistance during treatment. Thus, it is urgent to discover the endogenous...

Full description

Saved in:
Bibliographic Details
Published inBiochimica et biophysica acta. General subjects Vol. 1862; no. 4; pp. 1017 - 1030
Main Authors Feng, Fan, Jiang, Qiyu, Cao, Shuang, Cao, Yu, Li, Ruisheng, Shen, Lijun, Zhu, Hua, Wang, Tao, Sun, Lijun, Liang, Erguang, Sun, Huiwei, Chai, Yantao, Li, Xiaojuan, Liu, Genyan, Yang, Ruichang, Yang, Zhi, Yang, Yongping, Xin, Shaojie, Li, Bo-an
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.04.2018
Subjects
Online AccessGet full text

Cover

Loading…